Nerve Repair and Re generation Biologic Products Sales

Nerve Repair and Regeneration Biologic Products Sales Market Outlook

The global Nerve Repair and Regeneration Biologic Products market is projected to reach approximately USD 12 billion by 2035, growing at a robust CAGR of around 12.5% during the forecast period from 2025 to 2035. This growth can be attributed to several key factors, including the rising incidence of nerve injuries and neurological disorders, increased awareness regarding various nerve repair techniques, and advancements in medical technology that enhance surgical outcomes. Moreover, the growing geriatric population, which is more susceptible to nerve-related ailments, is further propelling the demand for advanced nerve repair products. Innovative research and development in biologic products, such as nerve conduits and growth factor applications, are also significantly contributing to market expansion. As healthcare systems continue to evolve, there is a noticeable shift towards minimally invasive procedures, which is expected to favor the adoption of nerve repair and regeneration biologic products.

Growth Factor of the Market

The Nerve Repair and Regeneration Biologic Products market is largely driven by several growth factors that are reshaping the landscape of neurological treatments. One of the most critical factors is the increasing prevalence of neurological disorders, which is prompting healthcare professionals to seek effective treatment solutions. Additionally, advancements in nerve repair technologies, such as the development of bioengineered nerve conduits, have led to improved recovery rates for patients. The rising number of surgical procedures focused on nerve repair, supported by a growing understanding of regenerative medicine, is also fueling market growth. Furthermore, the heightened focus on research and development initiatives by leading healthcare organizations is paving the way for innovative therapies, ultimately enhancing patient outcomes. Public and private investments in healthcare infrastructure, especially in regions with high incidences of nerve injuries, are expected to further accelerate the market's growth trajectory.

Key Highlights of the Market

• The market is expected to achieve a valuation of approximately USD 12 billion by 2035.
• The CAGR during the forecast period (2025-2035) is estimated to be around 12.5%.
• Technological advancements in nerve repair solutions play a significant role in market expansion.
• The growing elderly population is a major demographic driving demand for nerve repair products.
• Research and development initiatives are leading to innovative treatment options in the market.

By Product Type

Nerve Conduit Grafts:

Nerve conduit grafts are one of the most critical product types in the Nerve Repair and Regeneration market, specifically designed to facilitate the regeneration of damaged nerves. These conduits provide a supportive environment for axonal growth, thereby promoting successful nerve repair. The use of biocompatible materials in these grafts ensures they do not elicit adverse reactions in patients, making them a preferred choice for surgeons. Furthermore, the availability of various types of conduits, such as hollow tubes and those infused with growth factors, enhances their effectiveness. With increasing surgical procedures focusing on peripheral nerve repair, the demand for nerve conduit grafts is anticipated to witness significant growth in the coming years. Overall, their role in bridging gaps between nerve ends is pivotal in achieving favorable surgical outcomes.

Nerve Wrap:

Nerve wraps are specialized products designed to provide protection and support to injured nerves during the healing process. These wraps are especially beneficial in cases where nerve injuries may not be severe enough to warrant surgical intervention but still require stabilization to promote healing. The materials used in nerve wraps are often bioresorbable, ensuring they break down safely in the body without requiring additional procedures for removal. The increasing prevalence of sports-related injuries and accidents leading to nerve damage has contributed to the rising demand for nerve wraps. Additionally, the continuous innovation in materials and designs is enhancing the functional properties of nerve wraps, making them a crucial element in the nerve repair landscape.

Nerve Connector:

Nerve connectors serve as critical components in the nerve repair process by directly linking severed nerve ends, thereby facilitating proper regeneration. These connectors are engineered to align the nerve tissues accurately, significantly influencing the speed and effectiveness of nerve regeneration. Their application is particularly beneficial in cases involving nerve transection or severe injury where conventional methods might not suffice. As advancements in technology continue, the efficiency and effectiveness of nerve connectors are expected to improve, leading to increased adoption in clinical settings. This segment is anticipated to grow substantially as more healthcare providers recognize the benefits of utilizing nerve connectors in surgical procedures.

Neurostimulation Devices:

Neurostimulation devices are emerging as a transformative segment within the Nerve Repair and Regeneration market. These devices are designed to help modulate nerve activity through electrical stimulation, providing therapeutic benefits to patients suffering from chronic pain or nerve damage. The effectiveness of neurostimulation has been supported by numerous clinical studies, leading to wider acceptance among healthcare professionals. As advancements in technology continue to enhance the capabilities of these devices, including increases in precision and patient comfort, their market presence is expected to grow. With more patients seeking alternatives to traditional pain management therapies, neurostimulation devices represent a promising opportunity within the broader scope of nerve repair and regeneration.

Others:

The 'Others' category in the product type segment encompasses a range of innovative products and solutions designed for nerve repair and regeneration. This includes emerging technologies and biologics that may not fit into traditional classifications but offer potential benefits for nerve healing. Products such as nerve growth factor-infused gels, advanced surgical instruments, and even wearable devices that support nerve regeneration fall into this category. As research in nerve repair continues to evolve, the introduction of novel therapies and solutions is likely to bolster this segment further. With the rise of personalized medicine, the potential for customized nerve repair solutions is also being explored, promising exciting developments in the coming years.

By Application

Hospitals:

Hospitals play a crucial role in the application of nerve repair and regeneration biologic products, serving as primary centers for surgical interventions and advanced treatment. The comprehensive infrastructure and access to skilled healthcare professionals allow hospitals to implement cutting-edge techniques for nerve repair. The increasing volume of surgical procedures performed in hospitals, especially in neurosurgery and orthopedic departments, has driven the demand for nerve repair products in this setting. Additionally, with advancements in healthcare technology, hospitals are increasingly adopting minimally invasive techniques, which are less traumatic for patients and lead to faster recovery times. As hospitals continue to invest in state-of-the-art medical equipment and training, the application of nerve biologics is expected to expand significantly.

Ambulatory Surgical Centers:

Ambulatory surgical centers (ASCs) have emerged as vital contributors to the Nerve Repair and Regeneration market due to their focus on outpatient procedures. ASCs offer a streamlined approach to surgeries, allowing patients to undergo nerve repair operations and return home the same day. This convenience, combined with cost-effectiveness, has led to a rise in the number of procedures performed in these settings. As ASCs adopt advanced nerve repair technologies, including biologics and minimally invasive techniques, they are becoming increasingly popular among both patients and healthcare providers. The growing preference for outpatient care and the focus on enhancing patient experiences are anticipated to drive the application of nerve repair products in ASCs.

Specialty Clinics:

Specialty clinics have become integral in the delivery of nerve repair and regeneration therapies, offering targeted treatment options for patients with specific nerve injuries or conditions. These clinics often focus on particular areas, such as pain management, orthopedic treatment, or neurology, allowing for specialized expertise in nerve repair. The growing recognition of the benefits of tailored treatment plans has led to an increase in patient referrals to these clinics, further driving demand for nerve biologics. Additionally, specialty clinics often stay abreast of the latest research and advancements in nerve repair, ensuring they offer cutting-edge solutions. As the healthcare landscape evolves, the role of specialty clinics in nerve repair is expected to become even more pronounced.

Others:

The 'Others' category in the application segment encompasses a variety of healthcare settings where nerve repair and regeneration biologics may be utilized, including rehabilitation centers, academic research institutions, and home care scenarios. These settings often adopt innovative approaches to nerve repair, focusing on complementary therapies and rehabilitation techniques. In rehabilitation centers, for example, the integration of biologics into physical therapy can enhance recovery times and improve overall outcomes for patients. As research institutions explore new treatments and methodologies in nerve repair, the data generated can contribute to the broader understanding of nerve regeneration and inform clinical applications. The diverse nature of these applications suggests a wide potential for market growth across various healthcare environments.

By Distribution Channel

Direct Sales:

Direct sales are a significant distribution channel in the Nerve Repair and Regeneration market, providing manufacturers with a straightforward approach to reach healthcare providers. This method allows for stronger relationships to be built between manufacturers and medical professionals, ensuring that users receive comprehensive product knowledge and support. Direct sales also enable companies to gather valuable feedback from practitioners, which can be utilized to enhance product offerings and address market demands effectively. As healthcare providers increasingly seek personalized solutions, the direct sales approach is likely to become more prevalent, allowing for tailored services and direct communication between the stakeholders.

Distributor Sales:

Distributor sales represent another key distribution channel within the Nerve Repair and Regeneration market, serving as intermediaries that facilitate the movement of products from manufacturers to healthcare facilities. Distributors often have established networks and relationships within the healthcare sector, enabling them to effectively market and distribute nerve repair products. This channel can also help manufacturers penetrate markets that may be more challenging to reach directly, expanding their overall market presence. Additionally, distributors often provide logistical support and inventory management, allowing healthcare providers to access the products they need efficiently. As the demand for nerve repair products continues to rise, distributor sales are expected to play a crucial role in meeting market needs.

By Ingredient Type

Collagen:

Collagen is a widely utilized ingredient in nerve repair and regeneration biologics, primarily due to its natural compatibility with human tissues. This protein provides structural support and scaffolding for nerve regeneration, facilitating cellular attachment and growth. Collagen-based products can be engineered to maintain their structural integrity while also being biodegradable, ensuring they support the healing process without leaving harmful residues. As research continues to uncover the benefits of collagen in nerve repair, its application is becoming increasingly prominent, with a growing number of products incorporating this ingredient into their formulations. The inherent properties of collagen make it an ideal candidate for nerve repair solutions, thus driving its demand in the market.

Growth Factors:

Growth factors play a pivotal role in nerve repair and regeneration by promoting cellular proliferation, differentiation, and survival. These biologically active molecules can stimulate the regeneration of nerve tissues, enhancing the overall healing process. The incorporation of growth factors into nerve repair products is becoming more common, as they offer a targeted approach to facilitating nerve regeneration. Research has demonstrated that specific growth factors can significantly improve functional recovery in nerve-injured patients. As the understanding of growth factors continues to evolve, their application in nerve repair therapies is expected to expand, presenting significant opportunities for manufacturers in this market.

Stem Cells:

The use of stem cells in nerve repair and regeneration represents one of the most promising advancements in the field. Stem cells possess the unique ability to differentiate into various cell types, making them ideal candidates for repairing damaged nerve tissues. Their application can lead to improved outcomes in nerve regeneration, as they can not only replace lost cells but also secrete factors that promote healing. Ongoing research is focused on understanding how to optimize stem cell therapies for nerve injuries, and as breakthroughs occur, it is anticipated that their adoption in clinical settings will increase. The potential for stem cells to revolutionize nerve repair strategies is a key driver of their growing presence in the market.

Proteins:

Proteins are essential components in the Nerve Repair and Regeneration market, as they can serve various functions in promoting healing and regeneration. They can act as signaling molecules that facilitate communication between cells during the regeneration process, thereby supporting the reconstruction of nerve pathways. Additionally, proteins can provide structural support and contribute to the formation of new tissues. The development of protein-based biologics is becoming increasingly common, as manufacturers seek to harness their therapeutic potential in nerve repair scenarios. As research reveals new applications for proteins in nerve regeneration, their role in the market is expected to expand significantly, paving the way for innovative treatment solutions.

By Region

The regional analysis of the Nerve Repair and Regeneration Biologic Products market reveals distinct trends and growth opportunities across various geographical areas. North America holds a significant share of the market, driven by advanced healthcare infrastructure, a growing elderly population, and increasing incidence rates of neurological disorders. The North American market is expected to reach approximately USD 4.5 billion by 2035, with a CAGR of about 12% during the forecast period. The presence of key players and ongoing research initiatives in the region further solidify its position as a leader in the global market for nerve repair products. Additionally, increasing healthcare expenditures and rising awareness about advanced treatment options are fuelling market growth in this region.

Europe is also emerging as a vital market for nerve repair and regeneration biologic products, bolstered by a focus on innovative healthcare solutions and significant investments in research and development. The European market is projected to reach around USD 3 billion by 2035, with a CAGR of approximately 11% during the forecast period. Countries like Germany, France, and the United Kingdom are at the forefront of adopting new technologies in nerve repair, driven by favorable regulatory environments and government initiatives. Furthermore, the rising prevalence of nerve injuries and neurological conditions across Europe is expected to contribute to the increasing demand for specialized nerve repair products, making it a key region for future growth.

Opportunities

The Nerve Repair and Regeneration Biologic Products market is rife with opportunities, particularly in the realm of technology integration and novel product development. As advancements in regenerative medicine continue to progress, there exists a tremendous potential for the development of innovative biologic solutions that can significantly enhance patient outcomes. Companies that invest in research and development to create next-generation nerve repair products, including smart biomaterials that can respond to biological signals, are likely to gain a competitive edge. Additionally, collaboration between academic institutions and industry players can facilitate the translation of groundbreaking research into commercial products, thus accelerating the timeline for bringing effective therapies to market. The growing recognition of personalized medicine also presents an opportunity for tailored nerve repair solutions that cater to individual patient needs, further driving market growth.

Moreover, the increasing incidence of workplace-related injuries and the rising number of sports-related injuries globally create further opportunities for expanding the market for nerve repair products. Manufacturers who can develop specialized products and technologies aimed at these injury types will likely see increased demand. Furthermore, the rise of telemedicine and remote patient monitoring can facilitate better access to nerve repair treatments, especially in underserved regions. By leveraging digital health technologies, manufacturers can also improve patient engagement and education regarding nerve repair options, contributing to improved treatment adherence and outcomes. Overall, the intersection of technological advancements and growing healthcare demands positions the Nerve Repair and Regeneration Biologic Products market for significant growth in the coming years.

Threats

Despite the promising growth trajectory, the Nerve Repair and Regeneration Biologic Products market faces several threats that could impede its progress. One of the primary threats is the intense competition between established companies and new entrants seeking to capture market share. This competitive landscape may lead to price wars, which could adversely affect profit margins and hinder investment in research and development. Additionally, the evolving regulatory landscape regarding medical devices and biologics can pose challenges for manufacturers striving to bring innovative products to market. Navigating complex approval processes can delay the launch of new therapies, ultimately impacting a company’s competitiveness. Furthermore, the prevalence of adverse events associated with nerve repair procedures can result in heightened scrutiny from regulatory agencies, thereby increasing compliance costs for manufacturers.

In addition to competitive pressures, the market is also susceptible to economic fluctuations that can influence healthcare spending. During periods of economic downturn, healthcare budgets may be curtailed, leading to reduced investments in advanced medical technologies, including nerve repair products. This could limit access to cutting-edge therapies and impact patient care. Moreover, the rapid evolution of healthcare technology necessitates continuous innovation; companies that fail to keep pace risk losing market relevance. As new therapeutic options and alternatives emerge, established products may face obsolescence, further challenging manufacturers to invest in continual improvement. Overall, these threats must be carefully managed to sustain growth in the nerve repair and regeneration sector.

Competitor Outlook

• Axogen, Inc.
• Medtronic plc
• Collagen Matrix, Inc.
• Integra LifeSciences Corporation
• ConMed Corporation
• Theragenics Corporation
• Neurotech Pharmaceuticals, Inc.
• Boston Scientific Corporation
• Shanghai Huayi Medical Technology Co., Ltd.
• Neurogen Corporation
• Zimmer Biomet Holdings, Inc.
• Alphatec Spine, Inc.
• Synovis Micro Companies Alliance, Inc.
• Revance Therapeutics, Inc.
• Corline Biomedical AB

The competitive landscape of the Nerve Repair and Regeneration Biologic Products market is characterized by a diverse range of players, including established multinational corporations and emerging biotech companies. Major players like Axogen, Inc., Medtronic, and Integra LifeSciences are at the forefront, leveraging their extensive research and development capabilities to introduce innovative nerve repair solutions. These companies invest heavily in clinical trials and product development to maintain their competitive edge and capture market share. Additionally, partnerships and collaborations between industry leaders and research institutions are common, aiming to accelerate the introduction of new therapies and enhance technological advancements within the sector.

Furthermore, many companies are expanding their product portfolios through mergers and acquisitions to diversify their offerings and enhance their market presence. For instance, Medtronic's acquisition strategies have allowed it to integrate advanced nerve repair technologies, strengthening its position as a leader in the market. Similarly, companies like Boston Scientific and Zimmer Biomet are continually exploring new avenues for growth through strategic partnerships, aimed at enhancing their capabilities in nerve repair and regeneration. The focus on innovation and continuous improvement remains key to sustaining competitive advantages in this evolving market.

On the other hand, emerging players are seeking to disrupt the market with novel approaches and innovative products, capitalizing on niche segments within the nerve repair landscape. These companies often attract attention due to their unique technologies, such as bioengineered scaffolds or novel growth factor applications. As the market continues to evolve, the ability of both established and emerging companies to adapt to changing healthcare needs and technological advancements will significantly determine their success. Overall, the competitive outlook for the Nerve Repair and Regeneration Biologic Products market remains dynamic, with ongoing innovation and collaboration set to drive future growth.

• 1 Appendix

  • 1.1 List of Tables
  • 1.2 List of Figures

• 2 Introduction

  • 2.1 Market Definition
  • 2.2 Scope of the Report
  • 2.3 Study Assumptions
  • 2.4 Base Currency & Forecast Periods

• 3 Market Dynamics

  • 3.1 Market Growth Factors
  • 3.2 Economic & Global Events
  • 3.3 Innovation Trends
  • 3.4 Supply Chain Analysis

• 4 Consumer Behavior

  • 4.1 Market Trends
  • 4.2 Pricing Analysis
  • 4.3 Buyer Insights

• 5 Key Player Profiles

  • 5.1 Axogen, Inc.
    • 5.1.1 Business Overview
    • 5.1.2 Products & Services
    • 5.1.3 Financials
    • 5.1.4 Recent Developments
    • 5.1.5 SWOT Analysis
  • 5.2 Medtronic plc
    • 5.2.1 Business Overview
    • 5.2.2 Products & Services
    • 5.2.3 Financials
    • 5.2.4 Recent Developments
    • 5.2.5 SWOT Analysis
  • 5.3 ConMed Corporation
    • 5.3.1 Business Overview
    • 5.3.2 Products & Services
    • 5.3.3 Financials
    • 5.3.4 Recent Developments
    • 5.3.5 SWOT Analysis
  • 5.4 Alphatec Spine, Inc.
    • 5.4.1 Business Overview
    • 5.4.2 Products & Services
    • 5.4.3 Financials
    • 5.4.4 Recent Developments
    • 5.4.5 SWOT Analysis
  • 5.5 Neurogen Corporation
    • 5.5.1 Business Overview
    • 5.5.2 Products & Services
    • 5.5.3 Financials
    • 5.5.4 Recent Developments
    • 5.5.5 SWOT Analysis
  • 5.6 Collagen Matrix, Inc.
    • 5.6.1 Business Overview
    • 5.6.2 Products & Services
    • 5.6.3 Financials
    • 5.6.4 Recent Developments
    • 5.6.5 SWOT Analysis
  • 5.7 Corline Biomedical AB
    • 5.7.1 Business Overview
    • 5.7.2 Products & Services
    • 5.7.3 Financials
    • 5.7.4 Recent Developments
    • 5.7.5 SWOT Analysis
  • 5.8 Theragenics Corporation
    • 5.8.1 Business Overview
    • 5.8.2 Products & Services
    • 5.8.3 Financials
    • 5.8.4 Recent Developments
    • 5.8.5 SWOT Analysis
  • 5.9 Revance Therapeutics, Inc.
    • 5.9.1 Business Overview
    • 5.9.2 Products & Services
    • 5.9.3 Financials
    • 5.9.4 Recent Developments
    • 5.9.5 SWOT Analysis
  • 5.10 Zimmer Biomet Holdings, Inc.
    • 5.10.1 Business Overview
    • 5.10.2 Products & Services
    • 5.10.3 Financials
    • 5.10.4 Recent Developments
    • 5.10.5 SWOT Analysis
  • 5.11 Boston Scientific Corporation
    • 5.11.1 Business Overview
    • 5.11.2 Products & Services
    • 5.11.3 Financials
    • 5.11.4 Recent Developments
    • 5.11.5 SWOT Analysis
  • 5.12 Neurotech Pharmaceuticals, Inc.
    • 5.12.1 Business Overview
    • 5.12.2 Products & Services
    • 5.12.3 Financials
    • 5.12.4 Recent Developments
    • 5.12.5 SWOT Analysis
  • 5.13 Integra LifeSciences Corporation
    • 5.13.1 Business Overview
    • 5.13.2 Products & Services
    • 5.13.3 Financials
    • 5.13.4 Recent Developments
    • 5.13.5 SWOT Analysis
  • 5.14 Synovis Micro Companies Alliance, Inc.
    • 5.14.1 Business Overview
    • 5.14.2 Products & Services
    • 5.14.3 Financials
    • 5.14.4 Recent Developments
    • 5.14.5 SWOT Analysis
  • 5.15 Shanghai Huayi Medical Technology Co., Ltd.
    • 5.15.1 Business Overview
    • 5.15.2 Products & Services
    • 5.15.3 Financials
    • 5.15.4 Recent Developments
    • 5.15.5 SWOT Analysis

• 6 Market Segmentation

  • 6.1 Nerve Repair and Re generation Biologic Products Sales Market, By Application
    • 6.1.1 Hospitals
    • 6.1.2 Ambulatory Surgical Centers
    • 6.1.3 Specialty Clinics
    • 6.1.4 Others
  • 6.2 Nerve Repair and Re generation Biologic Products Sales Market, By Product Type
    • 6.2.1 Nerve Conduit Grafts
    • 6.2.2 Nerve Wrap
    • 6.2.3 Nerve Connector
    • 6.2.4 Neurostimulation Devices
    • 6.2.5 Others
  • 6.3 Nerve Repair and Re generation Biologic Products Sales Market, By Ingredient Type
    • 6.3.1 Collagen
    • 6.3.2 Growth Factors
    • 6.3.3 Stem Cells
    • 6.3.4 Proteins
  • 6.4 Nerve Repair and Re generation Biologic Products Sales Market, By Distribution Channel
    • 6.4.1 Direct Sales
    • 6.4.2 Distributor Sales

• 7 Competitive Analysis

  • 7.1 Key Player Comparison
  • 7.2 Market Share Analysis
  • 7.3 Investment Trends
  • 7.4 SWOT Analysis

• 8 Research Methodology

  • 8.1 Analysis Design
  • 8.2 Research Phases
  • 8.3 Study Timeline

• 9 Future Market Outlook

  • 9.1 Growth Forecast
  • 9.2 Market Evolution

• 10 Geographical Overview

  • 10.1 Europe - Market Analysis
    • 10.1.1 By Country
      • 10.1.1.1 UK
      • 10.1.1.2 France
      • 10.1.1.3 Germany
      • 10.1.1.4 Spain
      • 10.1.1.5 Italy
  • 10.2 Asia Pacific - Market Analysis
    • 10.2.1 By Country
      • 10.2.1.1 India
      • 10.2.1.2 China
      • 10.2.1.3 Japan
      • 10.2.1.4 South Korea
  • 10.3 Latin America - Market Analysis
    • 10.3.1 By Country
      • 10.3.1.1 Brazil
      • 10.3.1.2 Argentina
      • 10.3.1.3 Mexico
  • 10.4 North America - Market Analysis
    • 10.4.1 By Country
      • 10.4.1.1 USA
      • 10.4.1.2 Canada
  • 10.5 Middle East & Africa - Market Analysis
    • 10.5.1 By Country
      • 10.5.1.1 Middle East
      • 10.5.1.2 Africa
  • 10.6 Nerve Repair and Re generation Biologic Products Sales Market by Region

• 11 Global Economic Factors

  • 11.1 Inflation Impact
  • 11.2 Trade Policies

• 12 Technology & Innovation

  • 12.1 Emerging Technologies
  • 12.2 AI & Digital Trends
  • 12.3 Patent Research

• 13 Investment & Market Growth

  • 13.1 Funding Trends
  • 13.2 Future Market Projections

• 14 Market Overview & Key Insights

  • 14.1 Executive Summary
  • 14.2 Key Trends
  • 14.3 Market Challenges
  • 14.4 Regulatory Landscape

Segments Analyzed in the Report

The global Nerve Repair and Re generation Biologic Products Sales market is categorized based on

By Product Type

• Nerve Conduit Grafts
• Nerve Wrap
• Nerve Connector
• Neurostimulation Devices
• Others

By Application

• Hospitals
• Ambulatory Surgical Centers
• Specialty Clinics
• Others

By Distribution Channel

• Direct Sales
• Distributor Sales

By Ingredient Type

• Collagen
• Growth Factors
• Stem Cells
• Proteins

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Key Players

• Axogen, Inc.
• Medtronic plc
• Collagen Matrix, Inc.
• Integra LifeSciences Corporation
• ConMed Corporation
• Theragenics Corporation
• Neurotech Pharmaceuticals, Inc.
• Boston Scientific Corporation
• Shanghai Huayi Medical Technology Co., Ltd.
• Neurogen Corporation
• Zimmer Biomet Holdings, Inc.
• Alphatec Spine, Inc.
• Synovis Micro Companies Alliance, Inc.
• Revance Therapeutics, Inc.
• Corline Biomedical AB